This was the stock's third consecutive day of gains.

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.

We recently published a list of 10 Best Very Cheap Stocks To Buy Right Now. In this article, we are going to take a look at ...

February 20, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025, ...

Merck's stock sank after the company reported fourth-quarter and year-end 2024 earnings this morning. Although it narrowly beat Wall Street's revenue targets, weak guidance for 2025 disappointed ...

We recently published a list of 10 Most Oversold S&P 500 Stocks in 2024. In this article, we are going to take a look at ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $112.46, a high ...

Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings.

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical ...